Interactions of acyl carnitines and other lysins with erythrocytes and reconstituted erythrocyte lipoproteins.
D000818:Animals; D001059:Apoproteins / Q000378:metabolism; D002250:Carbon Radioisotopes; D002331:Carnitine / Q000494:pharmacology*; D002462:Cell Membrane / Q000032:analysis / Q000187:drug effects / Q000378:metabolism; D002784:Cholesterol / Q000378:metabolism; D002794:Choline / Q000494:pharmacology*; D002855:Chromatography, Thin Layer; D004355:Drug Stability; D004912:Erythrocytes / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D006461:Hemolysis; D006863:Hydrogen-Ion Concentration; D008074:Lipoproteins / Q000097:blood*; D008244:Lysophosphatidylcholines / Q000494:pharmacology*; D010169:Palmitic Acids / Q000494:pharmacology*; D010743:Phospholipids / Q000378:metabolism; D010761:Phosphorus Radioisotopes; D011485:Protein Binding; D051381:Rats; D013997:Time Factors; D014316:Tritium
D001059:Apoproteins; D002250:Carbon Radioisotopes; D008074:Lipoproteins; D008244:Lysophosphatidylcholines; D010169:Palmitic Acids; D010743:Phospholipids; D010761:Phosphorus Radioisotopes; D014316:Tritium; D002784:Cholesterol; D002794:Choline; D002331:Carnitine